Achilles Tendon Rupture In Recreational Athletes - Hobby-Ending Incident or Easily Treatable Injury? Current Insight Into Risk Factors, Treatment Options and Recovery Strategies
DOI:
https://doi.org/10.12775/QS.2025.38.57868Keywords
Achilles tendon rupture (ATR), Risk factors, Treatment, Rehabilitation, Return to sportAbstract
Introduction and aim of study: Achilles tendon rupture (ATR) is a significant injury, particularly for athletes. If not managed properly, it can lead to complications and hinder athletic performance. This study aims to synthesize existing knowledge on risk factors, treatment, and recovery associated with ATR, helping identify the optimal treatment pathway for a prompt return to sports. It will also highlight prevalent risk factors, aiding in injury prevention for patients and healthcare professionals.
Materials and methods: This literature review summarizes data from PubMed, Google Scholar, and other scientific sources on ATR. Key search terms included “Achilles tendon rupture treatment,” “risk factors,” “Achilles tendon injuries,” and “physiotherapy in ATR.”
Results: Various risk factors for ATR were identified, with some later proven irrelevant, while others remained significant. Treatment options include both non-operative and operative management, with minimally invasive techniques showing the best outcomes, however each method can be employed in specific indications. The recovery period typically lasts around six months, with rehabilitation being a key component. Other alternative methods and their benefits are being explored.
Conclusion: Optimal outcomes for ATR treatment are achieved through operative intervention, particularly minimally invasive surgery, paired with early rehabilitation. Physical therapy, blood-flow restriction training, and stretching can aid return to sport. Considering risk factors in all patients, especially athletes in contact sports, is crucial. The correct management of Achilles tendon rupture, consisting of early diagnosis, surgical treatment and appropriate rehabilitation, allows recreational athletes to return to their previous sports with a level of performance similar to that prior to the injury.
References
[1] D. Tarantino, S. Palermi, F. Sirico, B. Corrado, Achilles Tendon Rupture: Mechanisms of Injury, Principles of Rehabilitation and Return to Play, J. Funct. Morphol. Kinesiol. 5 (2020) 95. https://doi.org/10.3390/jfmk5040095.
[2] J. Wertz, M. Galli, J.R. Borchers, Achilles tendon rupture: risk assessment for aerial and ground athletes., Sports Health. 5 (2013) 407–9. https://doi.org/10.1177/1941738112472165.
[3] J. Leppilahti, S. Orava, Total Achilles tendon rupture. A review., Sports Med. 25 (1998) 79–100. https://doi.org/10.2165/00007256-199825020-00002.
[4] K. Yinger, B.R. Mandelbaum, L.C. Almekinders, Achilles rupture in the athlete. Current science and treatment., Clin. Podiatr. Med. Surg. 19 (2002) 231–50, v. https://doi.org/10.1016/s0891-8422(02)00002-2.
[5] N. Maffulli, Current concepts in the management of subcutaneous tears of the Achilles tendon., Bull. Hosp. Jt. Dis. 57 (1998) 152–8. http://www.ncbi.nlm.nih.gov/pubmed/9809181 (accessed December 29, 2024).
[6] T.A.H. Järvinen, P. Kannus, N. Maffulli, K.M. Khan, Achilles Tendon Disorders: Etiology and Epidemiology, Foot Ankle Clin. 10 (2005) 255–266. https://doi.org/10.1016/j.fcl.2005.01.013.
[7] F. Amendola, L. Barbasse, R. Carbonaro, M. Alessandri-Bonetti, G. Cottone, M. Riccio, F. De Francesco, L. Vaienti, K. Serror, The Acute Achilles Tendon Rupture: An Evidence-Based Approach from the Diagnosis to the Treatment., Medicina (Kaunas). 58 (2022). https://doi.org/10.3390/medicina58091195.
[8] S.A. Xergia, C. Tsarbou, N.I. Liveris, Μ. Hadjithoma, I.P. Tzanetakou, Risk factors for Achilles tendon rupture: an updated systematic review., Phys. Sportsmed. 51 (2023) 506–516. https://doi.org/10.1080/00913847.2022.2085505.
[9] Y. Ochen, R.B. Beks, M. van Heijl, F. Hietbrink, L.P.H. Leenen, D. van der Velde, M. Heng, O. van der Meijden, R.H.H. Groenwold, R.M. Houwert, Operative treatment versus nonoperative treatment of Achilles tendon ruptures: systematic review and meta-analysis., BMJ. 364 (2019) k5120. https://doi.org/10.1136/bmj.k5120.
[10] J. Spoendlin, C. Meier, S.S. Jick, C.R. Meier, Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study., J. Diabetes Complications. 30 (2016) 903–9. https://doi.org/10.1016/j.jdiacomp.2016.02.017.
[11] P.C. Noback, E.S. Jang, D.O. Cuellar, M. Seetharaman, E. Malagoli, J.K. Greisberg, J.T. Vosseller, Risk factors for achilles tendon rupture: A matched case control study., Injury. 48 (2017) 2342–2347. https://doi.org/10.1016/j.injury.2017.08.050.
[12] J. Spoendlin, C. Meier, S.S. Jick, C.R. Meier, Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study., Ann. Med. 47 (2015) 492–8. https://doi.org/10.3109/07853890.2015.1074272.
[13] A.E.C. Nichols, I. Oh, A.E. Loiselle, Effects of Type II Diabetes Mellitus on Tendon Homeostasis and Healing., J. Orthop. Res. 38 (2020) 13–22. https://doi.org/10.1002/jor.24388.
[14] F.M.A.P. Claessen, R.-J. de Vos, M. Reijman, D.E. Meuffels, Predictors of primary Achilles tendon ruptures., Sports Med. 44 (2014) 1241–59. https://doi.org/10.1007/s40279-014-0200-z.
[15] M. V Sankova, N.M. Beeraka, M. V Oganesyan, N.A. Rizaeva, A. V Sankov, O.S. Shelestova, K. V Bulygin, H. Vikram Pr, A.N. Barinov, A.K. Khalimova, Y. Padmanabha Reddy, B. Basappa, V.N. Nikolenko, Recent developments in Achilles tendon risk-analyzing rupture factors for enhanced injury prevention and clinical guidance: Current implications of regenerative medicine., J. Orthop. Transl. 49 (2024) 289–307. https://doi.org/10.1016/j.jot.2024.08.024.
[16] C. Couppé, R.B. Svensson, M. Kongsgaard, V. Kovanen, J.-F. Grosset, O. Snorgaard, J. Bencke, J.O. Larsen, T. Bandholm, T.M. Christensen, A. Boesen, I.C. Helmark, P. Aagaard, M. Kjaer, S.P. Magnusson, Human Achilles tendon glycation and function in diabetes., J. Appl. Physiol. 120 (2016) 130–7. https://doi.org/10.1152/japplphysiol.00547.2015.
[17] H. CJ, B. S, K. LM, S. DL, Incidence, Risk Factors, and Treatment of Achilles Tendon Rupture in Patients With End-Stage Renal Disease, Foot Ankle Int. 39 (2018). https://doi.org/10.1177/1071100718762089.
[18] D.R. Morales, J. Slattery, A. Pacurariu, L. Pinheiro, P. McGettigan, X. Kurz, Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study., Clin. Drug Investig. 39 (2019) 205–213. https://doi.org/10.1007/s40261-018-0729-y.
[19] R. Persson, S. Jick, Clinical implications of the association between fluoroquinolones and tendon rupture: The magnitude of the effect with and without corticosteroids., Br. J. Clin. Pharmacol. 85 (2019) 949–959. https://doi.org/10.1111/bcp.13879.
[20] A. Briones-Figueroa, W.A. Sifuentes-Giraldo, J.L. Morell-Hita, M. Vázquez-Díaz, Achilles Tendon Rupture Associated with the Use of Fluoroquinolones in Patients Over 60 Years of AGE: Experience From a Single Tertiary Centre., Reumatol. Clin. 17 (2021) 141–143. https://doi.org/10.1016/j.reuma.2019.08.004.
[21] A. Łukawski, J. Szałajska, K. Wojtach, F. Czyżewski, I. Wiak, F. Banyś, K. Bochen, F. Jasiński, A. Dziegciarczyk, W. Górska, Treating Chronic Tendinopathy: Physical Therapy, Surgery and Other Form of Therapy, Qual. Sport. 29 (2024) 55586. https://doi.org/10.12775/QS.2024.29.55586.
[22] P.W. Ackermann, D.A. Hart, General Overview and Summary of Concepts Regarding Tendon Disease Topics Addressed Related to Metabolic Disorders., Adv. Exp. Med. Biol. 920 (2016) 293–8. https://doi.org/10.1007/978-3-319-33943-6_28.
[23] S. J, L. JB, M. M, M. C, J. SS, M. CR, The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study, Drug Saf. 39 (2016). https://doi.org/10.1007/S40264-016-0462-5.
[24] C. Alves, D. Mendes, F.B. Marques, Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis., Eur. J. Clin. Pharmacol. 75 (2019) 1431–1443. https://doi.org/10.1007/s00228-019-02713-1.
[25] A.L. Godoy-Santos, H. Bruschini, J. Cury, M. Srougi, C. de Cesar-Netto, L.F. Fonseca, N. Maffulli, Fluoroquinolones and the Risk of Achilles Tendon Disorders: Update on a Neglected Complication., Urology. 113 (2018) 20–25. https://doi.org/10.1016/j.urology.2017.10.017.
[26] E. Kucharczyk, N. Kucharczyk, K. Pawłuszkiewicz, Impact of Fluoroquinolones on Tendon Health: A Comprehensive Overview for the General Population and Athletes, Qual. Sport. 31 (2024) 55763. https://doi.org/10.12775/QS.2024.31.55763.
[27] J. Spoendlin, C. Meier, S.S. Jick, C.R. Meier, Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study., Pharmacoepidemiol. Drug Saf. 25 (2016) 1116–1123. https://doi.org/10.1002/pds.4042.
[28] G.W. Hess, Achilles tendon rupture: a review of etiology, population, anatomy, risk factors, and injury prevention., Foot Ankle Spec. 3 (2010) 29–32. https://doi.org/10.1177/1938640009355191.
[29] S.G. Dakin, J. Newton, F.O. Martinez, R. Hedley, S. Gwilym, N. Jones, H.A.B. Reid, S. Wood, G. Wells, L. Appleton, K. Wheway, B. Watkins, A.J. Carr, Chronic inflammation is a feature of Achilles tendinopathy and rupture., Br. J. Sports Med. 52 (2018) 359–367. https://doi.org/10.1136/bjsports-2017-098161.
[30] D. Chen, J. Liu, Z. Zhu, Z. Zhang, D. Liu, L. Zheng, Hyperuricemia as an independent risk factor for achilles tendon rupture in male: a case-control study., J. Orthop. Surg. Res. 19 (2024) 215. https://doi.org/10.1186/s13018-024-04698-9.
[31] A.L. Gianakos, H. Hartman, G.M.M.J. Kerkhoffs, J. Calder, J.G. Kennedy, Sex differences in biomechanical properties of the Achilles tendon may predispose men to higher risk of injury: A systematic review., J. ISAKOS Jt. Disord. Orthop. Sport. Med. 9 (2024) 184–191. https://doi.org/10.1016/j.jisako.2023.11.001.
[32] J. Zabrzyński, J. Szukalski, Ł. Paczesny, D. Szwedowski, D. Grzanka, Cigarette smoking intensifies tendinopathy of the LHBT. A microscopic study after arthroscopic treatment., Pol. J. Pathol. 70 (2019) 134–138. https://doi.org/10.5114/pjp.2019.87104.
[33] P. R, J. SA, R. AM, R. AJ, Musculoskeletal manifestations of primary hyperparathyroidism, Clin. Rheumatol. 35 (2016). https://doi.org/10.1007/S10067-016-3450-3.
[34] Y.H. Park, T.J. Kim, G.W. Choi, H.J. Kim, Age is a risk factor for contralateral tendon rupture in patients with acute Achilles tendon rupture., Knee Surg. Sports Traumatol. Arthrosc. 28 (2020) 1625–1630. https://doi.org/10.1007/s00167-019-05380-y.
[35] M.K. Krill, J. Hoffman, J. Yang, J.D. Hodax, B.D. Owens, T.E. Hewett, Previous foot injuries associated with a greater likelihood of Achilles tendon ruptures in professional American football players., Phys. Sportsmed. 46 (2018) 342–348. https://doi.org/10.1080/00913847.2018.1482188.
[36] G. Sierra-Jimenez, A. Sanchez-Ortiz, F.J. Aceves-Avila, G. Hernandez-Rios, S. Durán-Barragán, C. Ramos-Remus, Tendinous and ligamentous derangements in systemic lupus erythematosus., J. Rheumatol. 35 (2008) 2187–91. https://doi.org/10.3899/jrheum.080255.
[37] van der E. DM, S. T, G. JC, S. NW, Rerupture rate after early weightbearing in operative versus conservative treatment of Achilles tendon ruptures: a meta-analysis, J. Foot Ankle Surg. 52 (2013). https://doi.org/10.1053/J.JFAS.2013.03.027.
[38] J. Huang, C. Wang, X. Ma, X. Wang, C. Zhang, L. Chen, Rehabilitation regimen after surgical treatment of acute Achilles tendon ruptures: a systematic review with meta-analysis., Am. J. Sports Med. 43 (2015) 1008–16. https://doi.org/10.1177/0363546514531014.
[39] J.A. Zellers, M. Christensen, I.L. Kjær, M.S. Rathleff, K.G. Silbernagel, Defining Components of Early Functional Rehabilitation for Acute Achilles Tendon Rupture: A Systematic Review., Orthop. J. Sport. Med. 7 (2019) 2325967119884071. https://doi.org/10.1177/2325967119884071.
[40] D. Seow, Y. Yasui, J.D.F. Calder, J.G. Kennedy, C.J. Pearce, Treatment of Acute Achilles Tendon Ruptures: A Systematic Review and Meta-analysis of Complication Rates With Best- and Worst-Case Analyses for Rerupture Rates., Am. J. Sports Med. 49 (2021) 3728–3748. https://doi.org/10.1177/0363546521998284.
[41] F. Shi, S. Wu, W. Cai, Y. Zhao, Multiple comparisons of the efficacy and safety for six treatments in Acute Achilles Tendon Rupture patients: A systematic review and network meta-analysis., Foot Ankle Surg. 27 (2021) 468–479. https://doi.org/10.1016/j.fas.2020.07.004.
[42] Y. Wu, Y. Mu, L. Yin, Z. Wang, W. Liu, H. Wan, Complications in the Management of Acute Achilles Tendon Rupture: A Systematic Review and Network Meta-analysis of 2060 Patients., Am. J. Sports Med. 47 (2019) 2251–2260. https://doi.org/10.1177/0363546518824601.
[43] A.K. Attia, K.M. Khamis, P. Dhooghe, J.T. Bariteau, S.A. Labib, M.S. Myerson, Outcomes and Complications of Open vs Minimally Invasive Surgical Repair of Acute Achilles Tendon Rupture: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Foot Ankle Orthop. 7 (2022) 2473011421S00095. https://doi.org/10.1177/2473011421S00095.
[44] A.W. Su, L. Bogunovic, J. Johnson, S. Klein, M.J. Matava, J. McCormick, M. V Smith, R.W. Wright, R.H. Brophy, Operative Versus Nonoperative Treatment of Acute Achilles Tendon Ruptures: A Pilot Economic Decision Analysis., Orthop. J. Sport. Med. 8 (2020) 2325967120909918. https://doi.org/10.1177/2325967120909918.
[45] A.P. Boesen, M.I. Boesen, R. Hansen, K.W. Barfod, A. Lenskjold, P. Malliaras, H. Langberg, Effect of Platelet-Rich Plasma on Nonsurgically Treated Acute Achilles Tendon Ruptures: A Randomized, Double-Blinded Prospective Study., Am. J. Sports Med. 48 (2020) 2268–2276. https://doi.org/10.1177/0363546520922541.
[46] D. Huang, D.T.A. Vithran, H.-L. Gong, M. Zeng, Z.-W. Tang, Z.-Z. Rao, J. Wen, S. Xiao, Effectiveness of platelet-rich plasma in the treatment of Achilles tendon disease., World J. Orthop. 14 (2023) 485–501. https://doi.org/10.5312/wjo.v14.i6.485.
[47] M.I. Madhi, O.E. Yausep, K. Khamdan, D. Trigkilidas, The use of PRP in treatment of Achilles Tendinopathy: A systematic review of literature. Study design: Systematic review of literature., Ann. Med. Surg. 55 (2020) 320–326. https://doi.org/10.1016/j.amsu.2020.04.042.
[48] M.C. Minniti, A.P. Statkevich, R.L. Kelly, V.P. Rigsby, M.M. Exline, D.I. Rhon, D. Clewley, The Safety of Blood Flow Restriction Training as a Therapeutic Intervention for Patients With Musculoskeletal Disorders: A Systematic Review., Am. J. Sports Med. 48 (2020) 1773–1785. https://doi.org/10.1177/0363546519882652.
[49] J.-M.E. Caldwell, J.T. Vosseller, Maximizing Return to Sports After Achilles Tendon Rupture in Athletes., Foot Ankle Clin. 24 (2019) 439–445. https://doi.org/10.1016/j.fcl.2019.04.003.
[50] C. Holm, M. Kjaer, P. Eliasson, Achilles tendon rupture--treatment and complications: a systematic review., Scand. J. Med. Sci. Sports. 25 (2015) e1-10. https://doi.org/10.1111/sms.12209.
[51] N.J. Bevilacqua, Treatment of the neglected Achilles tendon rupture., Clin. Podiatr. Med. Surg. 29 (2012) 291–9, viii. https://doi.org/10.1016/j.cpm.2012.01.004.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jakub Kędzia, Joanna Duda, Kinga Racisz, Paweł Racisz, Alicja Obcowska, Aleksandra Walendzik, Łukasz Sencerek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 36
Number of citations: 0
